GHK-Cu
GHK-Cu (Copper tripeptide-1)
A naturally occurring copper-binding tripeptide that the body makes on its own — and makes less of with age. The community runs it two completely different ways: rubbed on the skin as a cosmetic serum, where the science is real if modest, or injected for systemic repair, where the science mostly isn’t. The honest version of this peptide lives in that gap.
What it is
On the skin, people run it for firmness, fine lines, wound and scar healing, and overall skin quality — it’s one of the most-used ingredients in serious cosmetic chemistry. Injected, the community reaches for it as a repair and anti-aging signal: skin and hair quality, faster healing, and a long tail of anecdotal claims (hair regrowth, even gray-hair reversal) that the evidence does not back. The split matters: the topical use is the studied one.
Its real identity is that it’s endogenous — GHK is a fragment your own body liberates from collagen during tissue damage, a built-in repair signal that declines sharply with age (community lore cites a drop of roughly two-thirds by age 60). Bound to copper, it’s a vivid blue, and that copper is the whole story in both directions: it’s what drives the collagen and remodeling signaling people want, and it’s also why the loudest safety theme is copper overload — the same reactive metal that powers the repair can generate free radicals if you pile on too much. That’s why the community treats it as a peptide you cycle, not one you run forever.
Mechanism
GHK-Cu carries a copper ion into tissue and acts as a signaling molecule rather than a hormone: it modulates genes involved in tissue remodeling, shifts matrix-metalloproteinase activity, and supports collagen and elastin synthesis during wound repair. That remodeling signal is well-described in vitro and in animal wound models — it’s the basis for the cosmetic use. The systemic, injected claims extrapolate from that same wound-healing biology to whole-body anti-aging, which is where the evidence thins out to gene-expression data and anecdote.
Step 1 · it is already in you
Your body makes GHK on its own.
GHK is a tiny fragment your body frees from collagen when tissue is damaged — a built-in repair signal. The catch: you make far less of it with age.
Step 2 · the copper
It carries a copper ion.
Bound to copper, GHK becomes a courier, ferrying that copper into tissue. The copper is the whole story — in both directions.
Step 3 · the repair signal
It tells skin to remodel.
In the tissue it acts as a signal, not a hormone: it nudges collagen and elastin production and shifts the enzymes that remodel the skin's matrix.
Step 4 · the studied lane
On the skin, this is real.
Applied topically, that remodeling signal is the best-supported use — firmer skin, better wound and scar healing. This is the lane the evidence actually covers.
Step 5 · the other lane
Injected, it is mostly extrapolation.
The systemic, injected anti-aging claims stretch the same wound-healing biology to the whole body — where the human evidence thins out to gene-expression data and anecdote.
Step 6 · copper's double edge
The same copper can tip to harm.
Pile on too much and the reactive metal that powers repair starts generating free radicals. That is why the community cycles it and pairs it with zinc — not run forever.
The result
A real signal — in the right lane.
Genuinely useful where it is studied; a leap of faith where it is not. The honest move is topical for the proven benefit, caution on the rest.
Two evidence pictures under one name: topical wound-healing has real human data; the injected, systemic anti-aging use essentially none. Copper is both the benefit and the risk.
Standard dose
| Topical (best-studied route) | Serum/cream applied to clean skin, typically once or twice daily; concentration matters more than ‘dose’community |
|---|---|
| Injected community dose | ~2 mg/day SubQ is the most-cited research range; ~2–3 mg/day for general ‘prevention’ (proposed — pending dosing review)community |
| Reconstitution | Commonly a 50 mg vial; extra bacteriostatic water cited to dilute the copper at the injection sitecommunity |
| Cycling | Run in cycles (e.g. ~8 weeks on / 4 weeks off) specifically to avoid copper accumulation; pairing with zinc is widely advised to keep the copper–zinc balancecommunity |
Reconstitution calculator
U-100 · 100u = 1 mL= 300 units
For the injected route. The topical serum isn't reconstituted this way.
Set the vial size and water to match your product — amounts vary by supplier. This is unit-conversion math, not medical advice or a dosing recommendation.
Pushing higher— going beyond the standard dosecommunity
Side effects & cautions
Topically, it’s generally well tolerated — the most common complaints are mild redness, irritation, or breakouts, usually formulation-dependent. Injected, the standout is injection-site pain (frequently mentioned, attributed to the copper), plus the theoretical-but-real concern of copper overload with chronic high dosing, which is the reason cycling and zinc pairing dominate the conversation. There’s no serious human safety signal in the limited trial data, but there’s also no long-term systemic safety data to lean on — the caution here is honest uncertainty, not a known harm.
Stacking
Topically it’s often layered into a broader skincare routine rather than stacked with other peptides. On the injected side, the community pairs it less with other peptides than with a zinc supplement (to offset copper) — that copper–zinc balance is the most consistent ‘stack’ advice. People chasing healing sometimes run it alongside repair peptides, but there’s no established protocol for that combination.
Evidence & sources
Two very different evidence pictures under one name. The one solid human positive is topical wound healing — a randomized, placebo-controlled diabetic-ulcer trial showed faster closure. But the most rigorous cosmetic trial was negative on objective measures (only subjective satisfaction improved), and the popular hair-growth claim rests largely on a study that used a different copper peptide (AHK-Cu), not GHK-Cu. Most of the rest is in-vitro, gene-expression, or animal work. The injected, systemic anti-aging use has essentially no human trial support.
- Mulder GD et al. (1994)Human RCTGHK-Cu gel for diabetic neuropathic ulcers (randomized, placebo-controlled)Wound Repair Regen — faster closure vs placeboPMID 17147644 ↗
- Miller TR et al. (2006)Human RCTGHK-Cu on laser-resurfaced skin (randomized)Arch Facial Plast Surg — negative on objective endpointsPMID 16847171 ↗
- Pickart L, Thaler MM (1973)Animal / in-vitroDiscovery of GHK in human serumNature New Biology — original isolationPMID 4349963 ↗
- Siméon A et al. (1999)Animal / in-vitroGHK-Cu modulates matrix metalloproteinases in wound repairJ Invest Dermatol — in-vitro / animal mechanismPMID 10383745 ↗
- Pickart L, Margolina A (2018)ReviewRegenerative and protective actions of GHK-CuInt J Mol Sci — reviewPMID 29986520 ↗
- Pyo HK et al. (2007)Animal / in-vitroTripeptide-copper and hair growth (in vitro)Arch Pharm Res — frequently miscited for GHK-CuPMID 17703734 ↗